Best Practices and Enhanced Standards for Research “International norms, standards, and guidelines … are required to govern, manage and improve the quality.

Slides:



Advertisements
Similar presentations
EPAA Conference 5 November 2007 Georgette LALIS Enterprise and Industry DG European Commission The international dimension of regulatory acceptance.
Advertisements

July 2002 EU Conference on 3Rs Animal Experimentation - a controversial issue.
Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
.. Collaborations and Global Alliances for Health Mirta Roses Periago Director Collaborations and Global Alliances for Health Mirta Roses Periago Director.
World Health Organization
First Evaluation of Good Governance for Medicines Programme Brief Summary of Findings.
An Overview of Regulatory Harmonization Initiatives, Regulatory Networks and Collaboration In Latin America and the Caribbean Pan American Health Organization.
Expert Group Meeting on International Economic and Social Classifications United Nations Statistics Division May 2011, New York.
Responsible Sponsorship A case study Dr Birgit Whitman, Head of Research Governance.
Comprehensive M&E Systems
ICH-GCG June 2009 Pan American Health Organization CURRENT STATUS OF PAN AMERICAN NETWORK FOR DRUG REGULATORY HARMONIZATION (PANDRH): James Fitzgerald.
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
EFSA MANAGEMENT PLAN 2008 The Management Plan
THANK YOU!. Regional Adviser, Noncommunicable Diseases, WHO/EMRO Dr Ibtihal Fadhil.
Biosafety and Biosecurity Challenges in the Caribbean Region Valerie Wilson Caribbean Med Labs Foundation Anticipating Global Biosecurity Challenges Istanbul,
Toolkit for Mainstreaming HIV and AIDS in the Education Sector Guidelines for Development Cooperation Agencies.
March 2015 Inter-American Network for the Prevention of Violence and Crime.
XXX_DECRIPT_MON00/1 Quality and impact of Social Science and Operations Research by the Special Programme in Human Reproduction Department of Reproductive.
European Commission Introduction to the Community Programme for Employment and Social Solidarity PROGRESS
PAN AMERICAN NETWORK OF COLLABORATING AND REFERENCE CENTERS FOR SUSTAINABLE DEVELOPMENT AND ENVIRONMENTAL HEALTH Preparatory Meeting Cuernavaca, Morelos.
EUNetPaS is a project supported by a grant from the EAHC. The sole responsibility for the content of this presentation lies with the author(s). The EAHC.
Characterizing evidence in EMF risk assessment, Berlin, 4-5 May 2006 The WHO International EMF Project Dr E. van Deventer Radiation and Environmental Health.
Council on Health Research for Development Foro de investigación en Salud de Argentina Fijación de prioridades de investigación sanitaria: de la agenda.
ECLAC measurement activities on Information Society WSIS FORUM 2013 Measuring the WSIS targets 14 May, 2013 Geneva.
The Role of Peer Review in a Multilateral Framework on Competition Policy Andrea Bruce Investment Trade Policy UNCTAD Regional Seminar for Latin America.
WHO-Technical Briefing Seminar | October-November 2012 Dr Cécile Macé 1 |1 | Good Governance for Medicines Programme Dr Cécile Macé EMP/MPC.
Tracking national portfolios and assessing results Sub-regional Workshop for GEF Focal Points in West and Central Africa June 2008, Douala, Cameroon.
12/5/2015 Communication on Progress Elena Panova UN Global Compact Network Bulgaria.
Eurostat/UNSD Conference on International Outreach and Coordination in National Accounts for Sustainable Development and Growth 6-8 May, Luxembourg These.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Fifth Session of the Islamic Conference of Health Ministers Panel Discussion IV: NGO Involvement in the Improvement of Health Services in OIC Member Countries.
Observatories for the Health Workforce in Africa VIII REGIONAL MEETING OF THE OBSERVATORIES OF HUMAN RESOURCES FOR HEALTH IN THE AMERICAS LIMA, PERU
Biosafety Clearing House Training Workshop date place.
Putting Health in All Policies into Practice Dr Kira Fortune 1 To provide the context of the HiAP Regional Plan of Action 2 To illustrate how the HiAP.
CITEL – San Salvador | 16 April | Electromagnetic Fields: A WHO Perspective Dr E. van Deventer.
Public health, innovation and intellectual property 1 |1 | The Global Strategy on Public Health, Innovation and Intellectual Property Technical Briefing.
John N. Lavis, MD, PhD Professor and Canada Research Chair in Knowledge Transfer and Exchange McMaster University Program in Policy Decision-Making McMaster.
Update on ESCAP Work on Trade Facilitation and implementation of the ROC-TF mechanism Regional Organizations Cooperation Mechanism for Trade Facilitation.
Future needs for capacity building and recommendations to the OIE Dr Sarah Kahn Consultant to the OIE
Strategic Objective 4 To promote the exchange of experiences and regulatory knowledge between NRAs inside and outside PANDRH“ Lessons learned from international.
IPCC Key challenges facing communities, and approaches to solutions that enhance resilience: through NAPs Climate and Health Summit 2014 Investing.
45 th Session Advisory Committee on Health Research of the Pan American Health Organization (CAIS) Hamilton, ON, Canada 17 – 19 October 2012 Partnerships.
VICH Training Strategy Steven D. Vaughn, DVM Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine U.S. Food and Drug Administration.
A Framework for Assessing Needs Across Multiple States, Stakeholders, and Topic Areas Stephanie Wilkerson & Mary Styers REL Appalachia American Evaluation.
2010 James Fitzgerald Senior Advisor, Medicines and Health Technologies PAHO/WHO rd St Washington DC USA International Cooperation in Quality.
Steps for the Integration of Traditional Medicine in the National Health Care Delivery System 18 TH ICASA Special Session on Traditional Medicine 1 st.
5. Presentación general de la iniciativa REDD+ SES 5. Presentation of the REDD+ SES Initiative.
AFP Advocacy Communication Strategy Sarah Whitmarsh May 24, 2016.
Round Table: Future challenges for PANDRH CARICOM Perspective.
Impact: promoting the dissemination & utilization of research findings 45th Session of the ACHR/CAIS Hamilton, Canada October 17 – 19, 2012 Tomás Pantoja,
Governance Strengthen research governance and promote the definition of research agendas 45 TH SESSION OF THE ADVISORY COMMITTEE ON HEALTH RESEARCH OF.
European network for Health Technology Assessment | JA | EUnetHTA European network for Health Technology Assessment THL Info.
Quality Metrics of Performance of Research Ethics Committees Cristina E. Torres, PhD FERCAP Coordinator.
2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.
African Centre for Statistics United Nations Economic Commission for Africa Session 2 How to meeting countries needs: What has been done and way forward.
United Nations Statistics Division
Anne-Marie Yazbeck, PhD National Infoday, Sweden 2017
Social Protection Global Technical Team Retreat,
UNEP/Global Mechanism support for UNCCD reporting
LEISHMANIASIS RESEARCH NETWORK (REDELEISH): EXPERIENCE IN LATIN AMERICA 6th World Congress on Leishmaniasis 16th - 20th May 2017 Toledo Spain Joelle Rode1;
NACJJ Road Map Policy Oriented Meeting:
DRAFT Standards for the Accreditation of e-Learning Programs
Addressing violence against women in the Americas: the role of health systems Special Meeting of The Permanent Council On The Subject “Addressing Violence.
PAHO/WHO Research Policies and Strategies
Institutional Framework, Resources and Management
Scanning the environment: The global perspective on the integration of non-traditional data sources, administrative data and geospatial information Sub-regional.
SRH & HIV Linkages Agenda
Workshop Plenary Maintaining Protected Areas for Now and the Future
United Nations Statistics Division
Ðì SA Effective Monitoring and Evaluation of Progress on the SDGs Monitoring SDGs : the perspective of Armstat Learning Conference: Implementing.
Presentation transcript:

Best Practices and Enhanced Standards for Research “International norms, standards, and guidelines … are required to govern, manage and improve the quality of research; address inefficiencies…; promote transparency (related to planned, ongoing, and completed research); improves access to information” Basis: maintaining public trust & participation in research Need to develop systematic method to select, develop, adopt and evaluate new standards & in line with ethics principles.

1. Recommended Processes Technical Documents & Guides PAHO & Member States ≈ WHO Standards -training workshops on guideline development in Chile, Guatemala, Peru with support McMaster & Nat. Univ. Colombia -Glossary of guideline related terms in Spanish -Mapping of handbooks to elaborate guidelines as well as a repository of official guidelines

2. Clinical Trial Registration: Mapping legislation; help construct; advocate; monitor  Clear progress as highlighted by Luis-Gabriel  Peru: applied to become primary registry  Argentina: research registry  Canada TCPS research ethics guideline 2011:  Oct. 18, 2012: announcement of Health Canada clinical trial ‘registry’  Bireme/PAHO: Software development OPEN TRIALS permits establishment Spanish/Portugese/English Primary Registries for the Region  Development of software for RECs including 20 fields for trial registration (Coll. PAHO Bioethics Ctee & Pontificia Universidad Católica Paraná de Brazil  Monitoring of Trial Registration

Trial Registration: Publications  Reveiz L, Saenz C, Murasaki RT, Cuervo LG, Ramalho L. Progress and challenges of clinical trials registration in Latin America and the Caribbean's. Rev Peru Med Exp Salud Publica. 2011;28(4):  White L, Ortiz Z, Cuervo LG, Reveiz L. Clinical trial regulation in Argentina: overview and analysis of regulatory framework, use of existing tools, and researchers' perspectives to identify potential barriers. Rev Panam Salud Publica. 2011;30(5):  Trudo Lemmens & Candice Telfer, “L’accès à l’information et le droit à la santé : la transparence des essais cliniques comme une obligation dans le contexte des droits de l’homme” in Louise Lalonde, ed., Le droit, vecteur de la gouvernance en santé?Défis théoriques et enjeux pratiques de l’accès aux soins de la santé (Sherbrooke: Éditions Revue de Droit de l'Université de Sherbrooke)  Trudo Lemmens, “Reimagining Global Governance of Pharmaceutical Knowledge Through a Human Rights Kaleidoscope” (forthcoming 2013 Journal of Law, Medicine and Ethics)  Trudo Lemmens & Candice Telfer, “Access to Data and the Right to Health: The Human Rights Case for Clinical Trials Transparency” (2012) 31(1) American Journal of Law & Medicine  Matthew Herder, Francoise Baylis, Trudo Lemmens, Submission to Standing Senate Committee on Social Affairs, Science and Technology on Clinical Trials Registration and Access to Clinical Trials Data (2012)

3. Strengthen PAHO Research Standards: Implement Registry PAHO research; Mapping RECs; Capacity Building bioethics  Evaluation of the required modifications to research registry system  PAHOERC Standards Operation Procedures updated  Ethics Capacity building at PAHO  Development of an open source software to support the process of revision of RECs

4. Reporting Standards: Equator; assessment of reporting quality; and promotion of reporting standards  Development of the Spanish EQUATOR portal  Assessment Research Reporting Quality: Translation of a number of reporting guidelines into Spanish  Publications to advocate for adequate reporting of research & on reporting quality  e.g. Reveiz L, Sangalang S, Glujovsky D, et al. Characteristics of randomized controlled trials published in Latin America and the Caribbean according to funding source. Plos One (Peer review)  Contributions to develop standards for good clinical practice reports of experiences (i.e. maternal mortality)

5. Evipnet Standards  Training workshops for EVIPNet teams, on policy brief and deliberative dialogue - development under EVIPNet global standards (Mc Master and SURE): Capacity building for understanding the processes of knowledge translation and contributing to development of PB and DD with best standards.  Technical cooperation on PB and DD development provided to countries : Capacity building "learning by doing" in the reality of each country.

Plans 2012/13  Publication Policy on Guideline Development: make all guidelines in which PAHO is involved comply with PAHO/WHO standards  Promote Guideline Standards:  Training activities  Improvement in quality of PAHO guidelines

Plans 2012/13  Establish Regional Trial Registry Network:  Network Governance  Organizing knowledge; fostering communication on trial registration through workshops, conferences, newsletters and a website; presenting strategies for implementation of trial registration  Further Promote National Trial Registries & Promote Reporting Standards:  The “Open Trials” software  Monitoring of progress in regulatory initiatives trial registration  Results reporting and access to data initiatives  Promote Good Practices for Setting Research Priorities

Future  Improve standards Research Ethics Committees in Americas  Rapid Response mechanisms:  Evipnet’s team capacity work  Harmonized standards  Development and implementation of policies to increase the investment in research :  Identification of alternative sources of research funding  Strengthening south –south collaboration in research project

5.1. To promote the implementation of recommended processes for technical documents and guides at PAHO and Member States using scientific evidence in line with WHO standards Indicators: -analysis of financial flows for research for health -Analysis of research agendas and outputs, and organizational plans and priorities

5.2. promote development of validated indicators to assess and monitor the effects of investment in research and scientific production & alignment of research activities with research priorities Indicators: -analysis of financial flows for research for health -Analysis of research agendas and outputs, and organizational plans and priorities

5.3. Advocate development of research methods that promote better knowledge and standardization of the reporting and analysis of the equity and implementation aspects of qualitative and quantitative research and systematic reviews INDICATORS: - Analysis of research pubs. By PAHO staff ~ BIREME, EQUATOR & WAME recommendations & standards - Analysis of research publications from region ~ with international standards

5.4. Help create or access research for health inventories/registries that are comparable and integrated with WHO’s ICTR platform & adopt standard identifiers and data set collections that contribute to international registration efforts and international ethics and publication standards

5.5. Promote access, use, and further development of helpful organized collections & registries of research syntheses (systematic reviews, evidence summaries, policy briefs)

5.6. Support Member states in development of strategies and action plans, regulations, and incentives to strengthen adherence to research registration by building effective and efficient tools for determining and assessing the extent to which the research they conduct adheres to international good practice standards—including ethics, safety, and research management standards.  Indicators: PAHO Ethics Review Committee Annual report; analysis of the characteristics of studies submitted for review

5.7. Work in collaboration of stakeholders to promote the ethical regulation of research for health in humans and the strengthening of ethical review committees and commissions in Member States.

5.8. Promoting the notion that health care interventions must be subject to fair tests and evaluations (including interventions in alternative, traditional, and complementary medicine) in order to support wider access to safe and effective care and to protect individuals from interventions likely to be harmful or ineffective.  Indicators: countries with health technology agencies and processes requiring fair tests to balance the effects of interventions including benefits and harms.